AVENTIS PHARMA DEUTSCHLAND GMBH
Patent Owner
Stats
- 47 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 28, 2013 most recent publication
Details
- 47 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,204 Total Citation Count
- Mar 30, 1978 Earliest Filing
- 155 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8278430 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical useMar 11, 11Oct 02, 12[C07H]
8198030 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical useMar 21, 07Jun 12, 12[G01N]
7928066 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical useApr 25, 00Apr 19, 11[A61K, C07K]
7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticalsApr 13, 05Nov 27, 07[C07D]
6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitorJul 08, 00May 31, 05[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0317,047 PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILUREAbandonedNov 09, 12Nov 28, 13[A61K]
2011/0263,619 PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILUREAbandonedDec 01, 10Oct 27, 11[A61K, A61P]
2010/0267,798 PHARMACEUTICAL FORMULATIONS AND USE THEREOF IN THE PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILUREAbandonedNov 10, 09Oct 21, 10[A61K, A61P]
7662383 Chimeric antibody against tumor associated antigens and its use in diagnosing tumorsExpiredFeb 07, 08Feb 16, 10[A61K, C12P, C07K]
2009/0258,919 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failureAbandonedJun 16, 09Oct 15, 09[A61K, A61P]
7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligandsExpiredDec 21, 06Jun 23, 09[A61K, C07D]
2009/0023,661 Use of Antagonists of the Bradykinin B2 Receptor for the Treatment of OsteoarthrosisAbandonedSep 25, 08Jan 22, 09[A61K, A61P]
2008/0287,403 USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM IN THE PREVENTION OF CARDIOVASCULAR EVENTSAbandonedMay 22, 08Nov 20, 08[A61K, A61P]
7332607 Processes for the preparation of (R)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidin-emethanolExpiredMay 06, 04Feb 19, 08[C07C]
7241595 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugatesExpiredApr 24, 02Jul 10, 07[C12P]
7186724 Heterocyclic substituted carbonyl derivatives and their use as dopamine D.sub.3 receptor ligandsExpiredApr 06, 04Mar 06, 07[A61K]
2006/0159,682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereofAbandonedSep 17, 04Jul 20, 06[A61K, C07K]
2005/0255,071 Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitorsAbandonedJul 11, 05Nov 17, 05[A61K]
6962943 Gabusectin derivatives, processes for preparing them and their useExpiredNov 08, 02Nov 08, 05[A01P, A61K, C07D]
6926896 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereofExpiredDec 13, 94Aug 09, 05[A61K, C12P, C07K]
6919441 Polyamide-oligonucleotide derivatives, their preparation and useExpiredFeb 27, 01Jul 19, 05[C07H]
6908947 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising themExpiredOct 25, 01Jun 21, 05[A61K, C07C, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.